SK Bioscience Co.,Ltd
A global biotech firm developing vaccines for diseases like COVID-19, influenza, and shingles.
302440 | KO
Overview
Corporate Details
- ISIN(s):
- KR7302440003
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 판교로 310, 성남시
- Website:
- https://www.skbioscience.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
SK Bioscience is a global vaccine and biotechnology company dedicated to promoting human health through the research, development, and manufacturing of vaccines. Spun off from SK Chemicals in 2018, the company utilizes advanced platforms, including cell culture and recombinant protein technologies. Its portfolio of proprietary products includes SKYCovione™ (COVID-19), SKYCellflu® (the world's first cell-cultured quadrivalent influenza vaccine), SKY Zoster® (shingles), and SKY Varicella® (chickenpox). SK Bioscience actively expands its global presence through strategic collaborations with international partners and health organizations, such as the Bill & Melinda Gates Foundation, embodying its mission 'From Prevention To Cure'.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-19 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등거래계획보고서
|
Korean | 47.1 KB | ||
| 2025-09-19 00:00 |
Related Party Transaction
특수관계인에대한부동산매도
|
Korean | 5.2 KB | ||
| 2025-09-19 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 92.4 KB | ||
| 2025-08-29 00:00 |
Governance Information
대규모기업집단현황공시[분기별공시(개별회사용)]
|
Korean | 7.9 KB | ||
| 2025-08-13 00:00 |
Regulatory News Service
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
|
Korean | 11.0 KB | ||
| 2025-08-12 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 4.3 MB | ||
| 2025-07-31 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 15.0 KB | ||
| 2025-07-31 00:00 |
Report Publication Announcement
기업설명회(IR)개최(안내공시)
|
Korean | 6.1 KB | ||
| 2025-07-21 00:00 |
Report Publication Announcement
기업설명회(IR)개최(안내공시)
|
Korean | 6.1 KB | ||
| 2025-06-25 00:00 |
M&A Activity
[기재정정]타법인주식및출자증권취득결정(종속회사의주요경영사항)
|
Korean | 30.4 KB | ||
| 2025-06-09 00:00 |
Legal Proceedings Report
[기재정정]투자판단관련주요경영사항 (21가 폐렴구균백신(GBP410)의 미국 제3상 임상시험계획 (IND) 승인)
|
Korean | 32.5 KB | ||
| 2025-06-04 00:00 |
Regulatory News Service
단일판매ㆍ공급계약체결
|
Korean | 7.8 KB | ||
| 2025-05-30 00:00 |
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
|
Korean | 123.1 KB | ||
| 2025-05-30 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 2.9 MB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 2.0 MB |
Automate Your Workflow. Get a real-time feed of all SK Bioscience Co.,Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SK Bioscience Co.,Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SK Bioscience Co.,Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
